Price $40.75 |
Market Cap
2.03B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
59.0
|
P/B
3.08
|
P/S
3.05
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-
|
FCF
-
|
|
Op. Margin
5.10%
|
Net Margin
4.90%
|
ROE
5.70%
|
ROI
3.60%
|
|
ROA
3.30%
|
EPS Growth
37.40%
|
Current Ratio
2.8
|
Debt/Equity
63.10%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Encision Inc (ECIA) | $0.43 | - | - | 4.4M | Strong Buy |
| Bioanalytical Systems, Inc. (BASI) | $1.71 | - | - | 15.5M | Strong Buy |
| Senomyx Inc. (SNMX) | $0.60 | - | - | 37.1M | Strong Buy |
| Valeant Pharmaceuticals Intl I (VRX) | $14.39 | - | - | 5.95B | Strong Buy |
| Catasys, Inc. (CATS) | $5.09 | - | - | 68.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
